| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/05/2000 | EP0765308B1 Enzyme inhibitors |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046308 Isolated TRBP polypeptides and uses therefor |
| 04/04/2000 | US6046177 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| 04/04/2000 | US6046161 Use of hemoglobin in the treatment of cardiogenic shock |
| 03/30/2000 | WO2000017371A1 Polynucleotide constructs and uses thereof |
| 03/30/2000 | WO2000017360A1 Cystine knot growth factor mutants |
| 03/30/2000 | WO2000017354A1 Human isre-binding protein |
| 03/30/2000 | WO2000017222A1 31 human secreted proteins |
| 03/30/2000 | WO2000017204A1 INHIBITORS OF p38 |
| 03/30/2000 | WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 03/30/2000 | CA2344657A1 Human isre-binding protein |
| 03/30/2000 | CA2344277A1 Cystine knot growth factor mutants |
| 03/30/2000 | CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 03/30/2000 | CA2344100A1 31 human secreted proteins |
| 03/30/2000 | CA2343360A1 Human cytoskeleton associated proteins |
| 03/29/2000 | EP0988320A1 Cyclic crf agonists |
| 03/29/2000 | EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 03/29/2000 | CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine |
| 03/28/2000 | US6043235 11β-aryl-17, 17-spirothiolane-substituted steroids |
| 03/28/2000 | CA2109625C 3,5,3'-triiodothyronine receptor ligands |
| 03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
| 03/23/2000 | WO2000015793A2 Human gpcr proteins |
| 03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
| 03/23/2000 | WO2000015659A2 Stomach polypeptide zsig28 |
| 03/23/2000 | WO2000015609A1 Azetidine derivatives, preparation and medicines containing them |
| 03/23/2000 | WO2000015195A1 Quick release pharmaceutical compositions of drug substances |
| 03/23/2000 | WO2000015193A1 Mousse composition |
| 03/23/2000 | WO2000015176A2 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 03/23/2000 | WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/23/2000 | CA2343578A1 Human serine/threonine protein kinases |
| 03/23/2000 | CA2343133A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities |
| 03/23/2000 | CA2343001A1 Stomach polypeptide zsig28 |
| 03/23/2000 | CA2342833A1 Human gpcr proteins |
| 03/23/2000 | CA2342301A1 Human cell junction pdz protein |
| 03/22/2000 | EP0986574A1 11$g(b)-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS. |
| 03/22/2000 | EP0986557A1 Antagonists of gonadotropin releasing hormone |
| 03/22/2000 | EP0986550A1 Antagonists of gonadotropin releasing hormone |
| 03/22/2000 | EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
| 03/22/2000 | EP0986395A1 Peptide parathyroid hormone analogs |
| 03/22/2000 | EP0986385A1 Antagonists of gonadotropin releasing hormone |
| 03/22/2000 | CN1248263A Process for preparing carboxamido-4-azasteroids |
| 03/22/2000 | CN1248177A Coated particles, method of making and using |
| 03/21/2000 | US6040340 Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors |
| 03/21/2000 | US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 03/21/2000 | US6040289 Active drug treating obesity |
| 03/21/2000 | US6039948 Amino acid sequences with beta subunit of chorionic gonadotropin endogenous to mammals |
| 03/16/2000 | WO2000014236A2 Grf analogs with increased biological potency |
| 03/16/2000 | WO2000014106A1 Novel bag proteins and nucleic acid molecules encoding them |
| 03/16/2000 | WO2000014095A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/16/2000 | WO2000013650A2 Neuroprotection |
| 03/16/2000 | WO2000002881A3 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 03/16/2000 | WO1999064598A3 Novel insulin analogs with enhanced zinc binding |
| 03/16/2000 | WO1999061471A3 Human transmembrane proteins |
| 03/16/2000 | DE19841615A1 Medicinal wine for alleviating pain and other symptoms of premenstrual syndrome, comprising mixture of extracts of different plants in dry white wine |
| 03/16/2000 | CA2343214A1 Neuroprotection |
| 03/16/2000 | CA2343027A1 Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| 03/16/2000 | CA2342070A1 Grf analogs with increased biological potency |
| 03/16/2000 | CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them |
| 03/15/2000 | EP0985149A1 Methods for evaluating tissue morphogenesis and activity |
| 03/15/2000 | EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them |
| 03/15/2000 | EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
| 03/15/2000 | EP0723453B1 Method of treating reproductive disorders |
| 03/15/2000 | CN1247534A Benzofurazan compounds which enhance AMPA receptor activity |
| 03/14/2000 | US6037373 Treating nervous system, cytological, hormonal, gastrointestinal and liver disorders |
| 03/14/2000 | US6037173 Nucleic acid molecule that codes a thyroid receptor binding protein; for diagnosis and treatment of diseases associated with defects in the function of thyroid binding protein; for detection of mudulators of protein function |
| 03/09/2000 | WO2000012685A2 Genes associated with neurotransmitter processing |
| 03/09/2000 | WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites |
| 03/09/2000 | WO2000012087A1 Method for treating hot flashes in humans |
| 03/09/2000 | WO2000012067A1 Novel pharmaceutical salt form |
| 03/09/2000 | WO2000012047A2 Enhancement of return to independent living status with a growth hormone secretagogue |
| 03/09/2000 | CA2341649A1 Enhancement of return to independent living status with a growth hormone secretagogue |
| 03/09/2000 | CA2341522A1 Novel pharmaceutical salt form |
| 03/09/2000 | CA2340617A1 Genes associated with neurotransmitter processing |
| 03/08/2000 | EP0983992A2 Compounds having selectivity for retinoid x receptors |
| 03/08/2000 | EP0983991A2 Compounds having selectivity for retinoid x receptors |
| 03/08/2000 | CN1246868A Melanocortins |
| 03/08/2000 | CN1246865A Antigestagenic steroids with fluorinated 17 'alpha'-alkyl chair |
| 03/08/2000 | CN1246475A Corticotropin release factors antagonistic agent |
| 03/07/2000 | US6034216 Low molecular weight peptidomimetic growth hormone secretagogues |
| 03/07/2000 | US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation. |
| 03/02/2000 | WO2000011191A2 Tpl-2/cot kinase and methods of use |
| 03/02/2000 | WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent |
| 03/02/2000 | WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 03/02/2000 | WO2000010975A1 Oxindole derivatives as growth hormone releasers |
| 03/02/2000 | WO2000010541A1 Stable spray-dried protein formulations |
| 03/02/2000 | WO1999057263A9 Modifying the expression of the fsh beta gene by homologous recombination |
| 03/02/2000 | WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 03/02/2000 | DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition |
| 03/02/2000 | CA2339036A1 Tpl-2/cot kinase and methods of use |
| 03/01/2000 | EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production |
| 03/01/2000 | EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 03/01/2000 | EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
| 03/01/2000 | EP0981514A1 3-epi vitamin d2 compounds and uses thereof |
| 03/01/2000 | EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
| 03/01/2000 | CN1245713A Chinese medicine prescription special for enriching milk secretion |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |